Most sold healthcare stocks in Q1 2025
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q1 2025 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include LIFESTANCE HEALTH GROUP INC (LFST), HALEON PLC-ADR (HLN), NOVO-NORDISK A/S-SPONS ADR (NVO), OSCAR HEALTH INC - CLASS A (OSCR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LFST | LIFESTANCE HEALTH GROUP INC | -8,732,092 | -$65.9M | 1 | 2 | 0 | 1 | 3 |
| HLN | HALEON PLC-ADR | -8,383,178 | $50.1M | 1 | 2 | 4 | 0 | 10 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -6,173,206 | -$710.2M | 3 | 5 | 5 | 0 | 16 |
| OSCR | OSCAR HEALTH INC - CLASS A | -6,034,128 | -$83.1M | 2 | 0 | 3 | 4 | 7 |
| AVTR | AVANTOR INC | -4,588,555 | -$609.9M | 2 | 3 | 3 | 4 | 9 |
| ACCD | ACCOLADE INC | -4,550,864 | -$14.1M | 0 | 1 | 0 | 1 | 2 |
| ZOM | ZOMEDICA CORP | -4,335,591 | -$520.3K | 0 | 0 | 0 | 2 | 0 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -4,331,662 | -$292.2M | 3 | 6 | 5 | 4 | 17 |
| JNJ | JOHNSON & JOHNSON | -3,297,002 | -$360.2M | 8 | 11 | 14 | 3 | 40 |
| BMY | BRISTOL-MYERS SQUIBB CO | -3,178,618 | -$23.4M | 4 | 9 | 9 | 2 | 27 |
| BBIO | BRIDGEBIO PHARMA INC | -3,069,394 | $73.0M | 0 | 0 | 2 | 0 | 2 |
| ABT | ABBOTT LABORATORIES | -2,470,976 | $63.0M | 4 | 6 | 10 | 4 | 28 |
| COO | COOPER COS INC/THE | -2,132,742 | -$200.6M | 5 | 1 | 1 | 3 | 9 |
| SNY | SANOFI-ADR | -1,844,638 | $449.2M | 3 | 6 | 2 | 0 | 13 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -1,815,404 | $43.4M | 0 | 0 | 2 | 0 | 3 |
| MRK | MERCK & CO. INC. | -1,778,107 | -$241.5M | 7 | 11 | 14 | 5 | 36 |
| PRME | PRIME MEDICINE INC | -1,582,791 | -$7.9M | 3 | 0 | 1 | 1 | 4 |
| DVA | DAVITA INC | -1,236,285 | -$64.1M | 1 | 1 | 3 | 2 | 6 |
| KPTI | KARYOPHARM THERAPEUTICS INC | -1,202,590 | -$813.3K | 0 | 0 | 0 | 1 | 0 |
| TRVI | TREVI THERAPEUTICS INC | -1,183,708 | $2.3M | 0 | 0 | 2 | 0 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -1,166,345 | -$42.3M | 2 | 5 | 0 | 2 | 7 |
| GILD | GILEAD SCIENCES INC | -1,152,661 | $695.7M | 4 | 7 | 9 | 2 | 21 |
| SYK | STRYKER CORP | -1,059,042 | -$247.0M | 3 | 6 | 10 | 2 | 25 |
| CRL | CHARLES RIVER LABORATORIES | -1,043,664 | -$230.9M | 1 | 2 | 2 | 3 | 6 |
| CAH | CARDINAL HEALTH INC | -1,027,181 | -$100.2M | 3 | 4 | 2 | 1 | 10 |
| CNC | CENTENE CORP | -990,689 | -$60.0M | 3 | 1 | 2 | 4 | 8 |
| ELEV | ELEVATION ONCOLOGY INC | -956,009 | -$734.3K | 0 | 0 | 1 | 0 | 1 |
| RPTX | REPARE THERAPEUTICS INC | -924,313 | -$1.7M | 0 | 0 | 2 | 0 | 2 |
| TSHA | TAYSHA GENE THERAPIES INC | -878,448 | -$1.6M | 0 | 0 | 0 | 1 | 2 |
| NVAX | NOVAVAX INC | -877,921 | -$8.1M | 0 | 2 | 1 | 2 | 4 |
| FGEN | FIBROGEN INC | -877,447 | -$570.3K | 0 | 0 | 1 | 0 | 1 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | -824,100 | -$1.8M | 0 | 0 | 1 | 0 | 1 |
| DHR | DANAHER CORP | -771,898 | -$365.4M | 5 | 6 | 5 | 5 | 22 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -745,200 | -$2.4M | 0 | 0 | 1 | 0 | 2 |
| EWTX | EDGEWISE THERAPEUTICS INC | -734,951 | -$21.9M | 0 | 0 | 1 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | -727,018 | -$522.4M | 3 | 10 | 10 | 4 | 29 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -712,665 | -$1.0M | 0 | 0 | 1 | 1 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | -700,249 | -$8.6M | 1 | 1 | 1 | 1 | 4 |
| OM | OUTSET MEDICAL INC | -686,748 | -$762.3K | 0 | 0 | 0 | 1 | 0 |
| NVS | NOVARTIS AG-SPONSORED ADR | -682,972 | $137.0M | 3 | 3 | 6 | 0 | 14 |
| UNH | UNITEDHEALTH GROUP INC | -664,235 | -$71.1M | 4 | 15 | 22 | 8 | 47 |
| ALHC | ALIGNMENT HEALTHCARE INC | -635,053 | $35.0M | 2 | 1 | 1 | 0 | 4 |
| PFE | PFIZER INC | -607,088 | -$44.6M | 6 | 16 | 10 | 2 | 35 |
| HOLX | HOLOGIC INC | -575,815 | -$93.4M | 4 | 5 | 4 | 1 | 13 |
| RDY | DR. REDDY'S LABORATORIES-ADR | -569,320 | -$33.6M | 1 | 0 | 3 | 0 | 4 |
| ACHL | ACHILLES THERAPEUTICS PL-ADR | -547,233 | -$623.8K | 0 | 0 | 0 | 1 | 0 |
| ESPR | ESPERION THERAPEUTICS INC | -503,800 | -$1.4M | 0 | 1 | 0 | 1 | 1 |
| CDNA | CAREDX INC | -489,212 | -$24.8M | 1 | 0 | 3 | 0 | 4 |
| CRDF | CARDIFF ONCOLOGY INC | -483,090 | -$2.1M | 0 | 0 | 0 | 1 | 0 |
| EXEL | EXELIXIS INC | -437,481 | $39.6M | 3 | 2 | 2 | 1 | 7 |